Project Scope |
Problem Statement |
---|
The clinical study analysis and reporting QC process has not changed in decades. It is widely agreed that there is significant overhead in using double programming, and that this may need to be revisited to accelerate and optimally use programming resources. This process has not been revisited or analysed within a modern context. The purpose of this Working Group project would be to perform this analysis and report findings. The QC process has significant impact on the adoption of Git in statistical programming, specifically in the complexity in using Git in a way that does not disrupt the QC process. This will also impact on what is perceived as acceptable level of QC for submissions by the industry, including regulators. |
Project Scope |
The scope will include the following topics:
How might the increasing use of AI change the QC process? |
Project Leads | |
---|---|
Caroline Phares, Altair |
Matthew Finnemeyer, Vertex Pharmaceuticals Inc | Matthew_Finnemeyer@vrtx.com |
Korak Datta, AstraZeneca | korak.datta@astrazeneca.com |
Alex Pearce, PHUSE Project |
Assistant |
| Project AcceptedQ2 2025 | ||||||
---|---|---|---|---|---|---|---|
|
Objectives & Deliverables | Timelines |
---|---|
1. Principles for using Git and example workflow(s) in context of the current QC process 2. PHUSE white paper on Git for statistical programming, to cover:
3. Core education on Git for statistical programmers 4. Soft proposal for an alternative QC process using Git featuresWhite Paper | TBC |